Retrospective Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Dec 21, 2020; 26(47): 7550-7567
Published online Dec 21, 2020. doi: 10.3748/wjg.v26.i47.7550
Table 1 Baseline characteristics of patients with multiple gastrointestinal stromal tumors, n (%)

PKUPH patients, n = 121
Literature-based patients, n = 1611
Total patients, n = 1731
Sexn = 12n = 160n = 172
Female6 (50.00)96 (60.00)102 (59.30)
F/M1.001.481.46
Age in yrn = 12n = 161n = 173
Range53-888-848-88
≤ 200 (0.00)25 (15.63)25 (14.45)
21-400 (0.00)29 (18.12)29 (16.86)
41-602 (16.67)51 (31.88)53 (30.81)
61-809 (75.00)51 (31.88)60 (34.88)
> 801 (8.33)5 (3.13)6 (3.49)
Mean (SD)65.33 (9.48)48.70 (21.17)49.85 (20.99)
Symptomsn = 12n = 55n = 67
GI bleeding2 (16.67)31 (56.36)33 (49.25)
Hematochezia1 (8.33)13 (24.07)14 (21.21)
Anemia0 (0.00)11 (20.37)11 (16.67)
Hematemesis1 (8.33)2 (3.70)3 (4.55)
Incidental finding7 (58.33)15 (27.27)22 (32.83)
Abdominal pain2 (16.67)14 (25.45)16 (23.88)
Palpable mass0 (0.00)2 (3.64)2 (2.99)
Others1 (8.33)11 (20.00)12 (17.91)
Classificationn = 12n = 161n = 173
Sporadic multiple GIST10 (83.33)53 (32.92)63 (36.42)
NF-1 associated GIST2 (16.67)72 (44.72)74 (42.77)
Primary familial GIST0 (0.00)8 (4.97)8 (4.62)
Pediatric GIST0 (0.00)25 (15.53)25 (14.45)
Carney-Stratakis syndrome0 (0.00)0 (0.00)0 (0.00)
Carney triads0 (0.00)3 (1.86)3 (1.73)
Combined diseasesn = 12n = 161n = 173
GI tumors0 (0.00)3 (1.86)3 (1.73)
GU tumors0 (0.00)5 (3.11)5 (2.89)
Breast tumors1 (8.33)7 (4.35)8 (4.62)
Other tumors0 (0.00)5 (3.11)5 (2.89)